Subsequently, we used the TargetScan online database and found that LGALS8-AS1 could function as a ceRNA for miR-125b-5p, consequently counteracting the effects of miR-125b-5p on the migration and invasion of breast cancer in vitro. This evidence concerns the gene LGALS8 and breast carcinoma.